Join
Live feed
·
PRReleasevia Quantisnow
Evogene Ltd logo

Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases

ByQuantisnow·Wall Street's wire, on your screen.
EVGN· Evogene Ltd
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVGN (Evogene Ltd) and more on Quantisnow.